• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用机器学习模型预测非酒精性脂肪性肝病的 5 年风险:前瞻性队列研究。

Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.

机构信息

Department of Endocrinology, The First Affiliated Hospital of Ningbo University, Ningbo, China.

Health Science Center, Ningbo University, Ningbo, China.

出版信息

J Med Internet Res. 2023 Sep 12;25:e46891. doi: 10.2196/46891.

DOI:10.2196/46891
PMID:37698911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10523217/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) has emerged as a worldwide public health issue. Identifying and targeting populations at a heightened risk of developing NAFLD over a 5-year period can help reduce and delay adverse hepatic prognostic events.

OBJECTIVE

This study aimed to investigate the 5-year incidence of NAFLD in the Chinese population. It also aimed to establish and validate a machine learning model for predicting the 5-year NAFLD risk.

METHODS

The study population was derived from a 5-year prospective cohort study. A total of 6196 individuals without NAFLD who underwent health checkups in 2010 at Zhenhai Lianhua Hospital in Ningbo, China, were enrolled in this study. Extreme gradient boosting (XGBoost)-recursive feature elimination, combined with the least absolute shrinkage and selection operator (LASSO), was used to screen for characteristic predictors. A total of 6 machine learning models, namely logistic regression, decision tree, support vector machine, random forest, categorical boosting, and XGBoost, were utilized in the construction of a 5-year risk model for NAFLD. Hyperparameter optimization of the predictive model was performed in the training set, and a further evaluation of the model performance was carried out in the internal and external validation sets.

RESULTS

The 5-year incidence of NAFLD was 18.64% (n=1155) in the study population. We screened 11 predictors for risk prediction model construction. After the hyperparameter optimization, CatBoost demonstrated the best prediction performance in the training set, with an area under the receiver operating characteristic (AUROC) curve of 0.810 (95% CI 0.768-0.852). Logistic regression showed the best prediction performance in the internal and external validation sets, with AUROC curves of 0.778 (95% CI 0.759-0.794) and 0.806 (95% CI 0.788-0.821), respectively. The development of web-based calculators has enhanced the clinical feasibility of the risk prediction model.

CONCLUSIONS

Developing and validating machine learning models can aid in predicting which populations are at the highest risk of developing NAFLD over a 5-year period, thereby helping delay and reduce the occurrence of adverse liver prognostic events.

摘要

背景

非酒精性脂肪性肝病(NAFLD)已成为全球性的公共卫生问题。在 5 年内识别和针对发生 NAFLD 风险较高的人群,可以帮助减少和延迟不良肝脏预后事件的发生。

目的

本研究旨在调查中国人群中 NAFLD 的 5 年发生率,并建立和验证用于预测 5 年 NAFLD 风险的机器学习模型。

方法

研究人群来自一项为期 5 年的前瞻性队列研究。共纳入 2010 年在宁波镇海龙联医院进行健康检查且无 NAFLD 的 6196 名个体。采用极端梯度提升(XGBoost)-递归特征消除,结合最小绝对收缩和选择算子(LASSO),筛选特征预测因子。共构建了 6 种机器学习模型,包括逻辑回归、决策树、支持向量机、随机森林、分类提升和 XGBoost,用于构建 5 年 NAFLD 风险模型。在训练集中对预测模型的超参数进行优化,并在内部和外部验证集中进一步评估模型性能。

结果

研究人群的 5 年 NAFLD 发生率为 18.64%(n=1155)。我们筛选出 11 个预测因素用于构建风险预测模型。经过超参数优化,CatBoost 在训练集中的预测性能最佳,受试者工作特征(ROC)曲线下面积(AUROC)为 0.810(95%CI 0.768-0.852)。逻辑回归在内部和外部验证集中的预测性能最佳,AUROC 曲线下面积分别为 0.778(95%CI 0.759-0.794)和 0.806(95%CI 0.788-0.821)。基于网络的计算器的开发提高了风险预测模型的临床可行性。

结论

开发和验证机器学习模型可以帮助预测哪些人群在 5 年内发生 NAFLD 的风险最高,从而有助于延迟和减少不良肝脏预后事件的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/cddb749a3709/jmir_v25i1e46891_fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/aaa2c9b78883/jmir_v25i1e46891_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/3261b54adab4/jmir_v25i1e46891_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/f859fdec0902/jmir_v25i1e46891_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/3de656a691ce/jmir_v25i1e46891_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/b15c39c1bda1/jmir_v25i1e46891_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/93067e0864ff/jmir_v25i1e46891_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/8295d6f8e352/jmir_v25i1e46891_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/cddb749a3709/jmir_v25i1e46891_fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/aaa2c9b78883/jmir_v25i1e46891_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/3261b54adab4/jmir_v25i1e46891_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/f859fdec0902/jmir_v25i1e46891_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/3de656a691ce/jmir_v25i1e46891_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/b15c39c1bda1/jmir_v25i1e46891_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/93067e0864ff/jmir_v25i1e46891_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/8295d6f8e352/jmir_v25i1e46891_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd63/10523217/cddb749a3709/jmir_v25i1e46891_fig8.jpg

相似文献

1
Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.利用机器学习模型预测非酒精性脂肪性肝病的 5 年风险:前瞻性队列研究。
J Med Internet Res. 2023 Sep 12;25:e46891. doi: 10.2196/46891.
2
Development and validation of machine learning models for nonalcoholic fatty liver disease.机器学习模型在非酒精性脂肪性肝病中的开发和验证。
Hepatobiliary Pancreat Dis Int. 2023 Dec;22(6):615-621. doi: 10.1016/j.hbpd.2023.03.009. Epub 2023 Mar 25.
3
Development and Validation of an Explainable Machine Learning Model for Predicting Myocardial Injury After Noncardiac Surgery in Two Centers in China: Retrospective Study.中国两个中心用于预测非心脏手术后心肌损伤的可解释机器学习模型的开发与验证:一项回顾性研究
JMIR Aging. 2024 Jul 26;7:e54872. doi: 10.2196/54872.
4
Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study.比较和开发先进的机器学习工具预测非酒精性脂肪性肝病:一项扩展研究。
Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):409-415. doi: 10.1016/j.hbpd.2021.08.004. Epub 2021 Aug 14.
5
Predicting the risk of subclinical atherosclerosis based on interpretable machine models in a Chinese T2DM population.基于可解释的机器学习模型预测中国 2 型糖尿病患者亚临床动脉粥样硬化风险。
Front Endocrinol (Lausanne). 2024 Feb 27;15:1332982. doi: 10.3389/fendo.2024.1332982. eCollection 2024.
6
Development and validation of a machine learning-based framework for assessing metabolic-associated fatty liver disease risk.基于机器学习的代谢相关脂肪性肝病风险评估框架的开发与验证。
BMC Public Health. 2024 Sep 18;24(1):2545. doi: 10.1186/s12889-024-19882-z.
7
Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020.通过2017 - 2020年美国国家健康与营养检查调查(NHANES)的受控衰减参数评估非酒精性脂肪性肝病的自动化机器学习模型。
Digit Health. 2024 Aug 7;10:20552076241272535. doi: 10.1177/20552076241272535. eCollection 2024 Jan-Dec.
8
Combinatorial Use of Machine Learning and Logistic Regression for Predicting Carotid Plaque Risk Among 5.4 Million Adults With Fatty Liver Disease Receiving Health Check-Ups: Population-Based Cross-Sectional Study.机器学习与逻辑回归联合应用于预测 540 万脂肪肝患者的颈动脉斑块风险:基于人群的横断面研究。
JMIR Public Health Surveill. 2023 Sep 7;9:e47095. doi: 10.2196/47095.
9
A simple machine learning model for the prediction of acute kidney injury following noncardiac surgery in geriatric patients: a prospective cohort study.一种用于预测老年非心脏手术后急性肾损伤的简单机器学习模型:一项前瞻性队列研究。
BMC Geriatr. 2024 Jun 25;24(1):549. doi: 10.1186/s12877-024-05148-1.
10
Development of Cost-Effective Fatty Liver Disease Prediction Models in a Chinese Population: Statistical and Machine Learning Approaches.中国人群中具有成本效益的脂肪肝疾病预测模型的开发:统计和机器学习方法
JMIR Form Res. 2024 Feb 16;8:e53654. doi: 10.2196/53654.

引用本文的文献

1
Interpretable machine learning model for predicting MII oocyte retrieved following controlled ovarian stimulation: a retrospective cohort study of 24,976 IVF/ICSI cycles.用于预测控制性卵巢刺激后获卵数的可解释机器学习模型:一项对24976个体外受精/卵胞浆内单精子注射周期的回顾性队列研究
J Assist Reprod Genet. 2025 Aug 23. doi: 10.1007/s10815-025-03634-y.
2
Machine learning-based identification of biochemical markers to predict hepatic steatosis in patients at high metabolic risk.基于机器学习识别生化标志物以预测高代谢风险患者的肝脂肪变性
World J Gastroenterol. 2025 Jul 21;31(27):108200. doi: 10.3748/wjg.v31.i27.108200.
3
Risk factors of breast cancer patients developing multiple primary cancers: a retrospective study and establishing/testing of machine learning models.

本文引用的文献

1
Prediction of 30-day mortality in heart failure patients with hypoxic hepatitis: Development and external validation of an interpretable machine learning model.缺氧性肝炎所致心力衰竭患者30天死亡率的预测:一种可解释机器学习模型的开发与外部验证
Front Cardiovasc Med. 2022 Oct 28;9:1035675. doi: 10.3389/fcvm.2022.1035675. eCollection 2022.
2
Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients.糖尿病肾病患者高尿酸血症风险模型的建立与内部验证。
Front Public Health. 2022 Oct 19;10:863064. doi: 10.3389/fpubh.2022.863064. eCollection 2022.
3
Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.
乳腺癌患者发生多原发性癌症的危险因素:一项回顾性研究及机器学习模型的建立/测试
BMC Med Inform Decis Mak. 2025 Jul 25;25(1):277. doi: 10.1186/s12911-025-03086-5.
4
Machine learning survival models for Non-alcoholic fatty liver disease based on a health checkup cohort.基于健康体检队列的非酒精性脂肪性肝病机器学习生存模型
BMC Gastroenterol. 2025 Jul 15;25(1):518. doi: 10.1186/s12876-025-04120-6.
5
Two-Year Hypertension Incidence Risk Prediction in Populations in the Desert Regions of Northwest China: Prospective Cohort Study.中国西北沙漠地区人群两年高血压发病风险预测:前瞻性队列研究
J Med Internet Res. 2025 Mar 12;27:e68442. doi: 10.2196/68442.
6
Development and validation of machine learning models for MASLD: based on multiple potential screening indicators.基于多种潜在筛查指标的非酒精性脂肪性肝病机器学习模型的开发与验证
Front Endocrinol (Lausanne). 2025 Jan 21;15:1449064. doi: 10.3389/fendo.2024.1449064. eCollection 2024.
7
A prediction study on the occurrence risk of heart disease in older hypertensive patients based on machine learning.基于机器学习的老年高血压患者心脏病发生风险预测研究
BMC Geriatr. 2025 Jan 11;25(1):27. doi: 10.1186/s12877-025-05679-1.
8
ERBB3-related gene PBX1 is associated with prognosis in patients with HER2-positive breast cancer.ERBB3相关基因PBX1与HER2阳性乳腺癌患者的预后相关。
BMC Genom Data. 2025 Jan 10;26(1):2. doi: 10.1186/s12863-024-01292-0.
9
Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma.揭示肠道微生物群在预测食管鳞状细胞癌新辅助免疫化疗反应中的作用
Research (Wash D C). 2024 Nov 14;7:0529. doi: 10.34133/research.0529. eCollection 2024.
10
Advancing non-alcoholic fatty liver disease prediction: a comprehensive machine learning approach integrating SHAP interpretability and multi-cohort validation.推进非酒精性脂肪性肝病预测:一种综合机器学习方法,整合 SHAP 可解释性和多队列验证。
Front Endocrinol (Lausanne). 2024 Oct 8;15:1450317. doi: 10.3389/fendo.2024.1450317. eCollection 2024.
儿童肥胖相关非酒精性脂肪性肝病的临床谱转换及预测模型。
Front Endocrinol (Lausanne). 2022 Aug 31;13:986841. doi: 10.3389/fendo.2022.986841. eCollection 2022.
4
Development and validation of a carotid atherosclerosis risk prediction model based on a Chinese population.基于中国人群的颈动脉粥样硬化风险预测模型的开发与验证
Front Cardiovasc Med. 2022 Aug 2;9:946063. doi: 10.3389/fcvm.2022.946063. eCollection 2022.
5
Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China.中国西北地区非酒精性脂肪性肝病的危险因素及预测模型。
Sci Rep. 2022 Aug 16;12(1):13877. doi: 10.1038/s41598-022-17511-6.
6
Association between apolipoprotein B/A1 and the risk of metabolic dysfunction associated fatty liver disease according to different lipid profiles in a Chinese population: A cross-sectional study.在中国人群中,根据不同的血脂谱,载脂蛋白 B/A1 与代谢相关脂肪性肝病风险的关系:一项横断面研究。
Clin Chim Acta. 2022 Sep 1;534:138-145. doi: 10.1016/j.cca.2022.07.014. Epub 2022 Jul 26.
7
A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study.基于一般人群的内脏型肥胖非酒精性脂肪性肝病发病预测模型研究。
Front Public Health. 2022 Jun 23;10:895045. doi: 10.3389/fpubh.2022.895045. eCollection 2022.
8
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
9
Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study.非酒精性脂肪性肝病的临床转归:一项为期 11 年的随访研究。
BMJ Open. 2022 Jun 27;12(6):e054891. doi: 10.1136/bmjopen-2021-054891.
10
Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.人工智能在肝脏疾病中的应用:改善诊断、预后评估及反应预测
JHEP Rep. 2022 Feb 2;4(4):100443. doi: 10.1016/j.jhepr.2022.100443. eCollection 2022 Apr.